Brief: Crossject FY Net Loss Widens To EUR 10.7 Million
13/03/2019 17:55
March 13 (Reuters) - CROSSJECT SA ALCJ.PA :
* FY NET LOSS EUR 10.7 MILLION VERSUS LOSS OF EUR 7.6 MILLION YEAR AGO
* FY OPERATING LOSS EUR 11.6 MILLION VERSUS LOSS OF EUR 8.6 MILLION YEAR AGO
* EXPECTS PATENT SIGNATURES IN 2019
* FY OPERATING REVENUE EUR 3.5 MILLION VERSUS EUR 4.1 MILLION YEAR AGO
* SEES BROADER PERSPECTIVES FOR ZENEO CONSECUTIVE TO OPIOID OVERDOSES EPIDEMICS IN THE US
Source text for Eikon: ID:nGNE1H887M
Further company coverage: ALCJ.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure